These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

769 related articles for article (PubMed ID: 15299062)

  • 41. [The value of Sm-153-EDTMP for treatment of metastatic bone pain and improving quality of life].
    Jiang CY; Zhu BL; Zhang YJ
    Zhonghua Zhong Liu Za Zhi; 1994 Mar; 16(2):118-21. PubMed ID: 7523052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alpharadin, a 223Ra-based alpha-particle-emitting pharmaceutical for the treatment of bone metastases in patients with cancer.
    Liepe K
    Curr Opin Investig Drugs; 2009 Dec; 10(12):1346-58. PubMed ID: 19943206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review.
    Jong JM; Oprea-Lager DE; Hooft L; de Klerk JM; Bloemendal HJ; Verheul HM; Hoekstra OS; van den Eertwegh AJ
    Eur Urol; 2016 Sep; 70(3):416-26. PubMed ID: 26391636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiotherapy in the management of bone pain.
    Hoskin PJ
    Clin Orthop Relat Res; 1995 Mar; (312):105-19. PubMed ID: 7543390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Palliation of bone pain in metastatic prostate carcinoma. Value of radionuclide therapy with rhenium 186 HEDP].
    Klutmann S; Bohuslavizki KH
    MMW Fortschr Med; 1999 Nov; 141(44):38-9. PubMed ID: 10912142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Palliation of bone pain in patients with metastatic cancer using strontium-89 (Metastron).
    Kan MK
    Cancer Nurs; 1995 Aug; 18(4):286-91. PubMed ID: 7545083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Strontium-89 therapy for painful osseous metastatic prostate and breast cancer.
    Hansen DV; Holmes ER; Catton G; Thorne DA; Chadwick DH; Schmutz DA
    Am Fam Physician; 1993 Jun; 47(8):1795-800. PubMed ID: 7684554
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiopharmaceuticals for the palliation of painful bone metastases.
    Sinclair JM
    Am J Hosp Palliat Care; 2005; 22(5):338. PubMed ID: 16225354
    [No Abstract]   [Full Text] [Related]  

  • 49. Palliation of bone pain in prostate cancer using chemotherapy and strontium-89. A randomized phase II study.
    Nilsson S; Strang P; Ginman C; Zimmermann R; Edgren M; Nordström B; Ryberg M; Kälkner KM; Westlin JE
    J Pain Symptom Manage; 2005 Apr; 29(4):352-7. PubMed ID: 15857738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of radionuclides for the palliation of bone metastases.
    McEwan AJ
    Semin Radiat Oncol; 2000 Apr; 10(2):103-14. PubMed ID: 10727599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Our experience on pain palliation of bone metastasis with Sr-89 or Sm-153 in cancer patients resistant to a conventional analgesic therapy. A retrospective study.
    Montesano T; Giacomobono S; Acqualagna G; Colandrea M; Di Nicola A; Travascio L; Giancamerla M; D'Apollo R; Toteda M; Ugolini F; Filesi M; Ronga G
    Clin Ter; 2009; 160(3):193-9. PubMed ID: 19756320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The tolerance and therapeutic efficacy of rhenium-188 hydroxyethylidene diphosphonate in advanced cancer patients with painful osseous metastases.
    Cheng A; Chen S; Zhang Y; Yin D; Dong M
    Cancer Biother Radiopharm; 2011 Apr; 26(2):237-44. PubMed ID: 21539455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radionuclide therapy for painful bone metastases. An Italian multicentre observational study. Writing Committee of an Ad Hoc Study Group.
    Piffanelli A; Dafermou A; Giganti M; Colamussi P; Pizzocaro C; Bestagno M;
    Q J Nucl Med; 2001 Mar; 45(1):100-7. PubMed ID: 11456368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patterns of practice in palliative radiotherapy for painful bone metastases: impact of a regional rapid access clinic on access to care.
    Wu JS; Kerba M; Wong RK; Mckimmon E; Eigl B; Hagen NA
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):533-8. PubMed ID: 19910133
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after (186)Re-HEDP therapy.
    Zafeirakis A; Zissimopoulos A; Baziotis N; Limouris GS
    Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):91-102. PubMed ID: 21068716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Palliative radiotherapy for painful bone metastases from solid tumors delivered with static ports of tomotherapy (TomoDirect): feasibility and clinical results.
    Franco P; Migliaccio F; Angelini V; Cante D; Sciacero P; Peruzzo Cornetto A; Casanova Borca V; Zeverino M; Torielli P; Arrichiello C; Girelli G; La Porta MR; Tofani S; Numico G; Ricardi U
    Cancer Invest; 2014 Nov; 32(9):458-63. PubMed ID: 25259607
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The treatment of painful osseous metastases with phosphorus-32-labeled phosphates.
    Silberstein EB
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):10-21. PubMed ID: 7684860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiopharmaceuticals for bone malignancy therapy.
    Atkins HL; Srivastava SC
    J Nucl Med Technol; 1998 Jun; 26(2):80-3; quiz 85-6. PubMed ID: 9604827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 153Sm-EDTMP for bone pain palliation in skeletal metastases.
    Maini CL; Bergomi S; Romano L; Sciuto R
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S171-8. PubMed ID: 15127241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new look at radionuclides therapy in metastatic disease of bone (review and prospects).
    Kim SI; Chen DC; Muggia FM
    Anticancer Res; 1988; 8(4):681-4. PubMed ID: 2460020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.